These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20889171)

  • 1. [Etiology and sensitivity of uropathogens identified in uncomplicated lower urinary tract infections in women (ARESC Study): implications on empiric therapy].
    Palou J; Pigrau C; Molina I; Ledesma JM; Angulo J;
    Med Clin (Barc); 2011 Jan; 136(1):1-7. PubMed ID: 20889171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uncomplicated lower urinary tract infections in females--clinical aspects, aetiology and antimicrobial resistance epidemiology. Results of the ARESC (Antimicrobial Resistance Epidemiological Survey on Cystitis) study in Poland and their implications for empiric therapy].
    Chlabicz S; Leszczynska K; Lukas W; Gualco L; Schito G; Naber KG
    Przegl Epidemiol; 2011; 65(2):345-51. PubMed ID: 21913487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. French results of the ARESC study: clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy.
    Neuzillet Y; Naber KG; Schito G; Gualco L; Botto H
    Med Mal Infect; 2012 Feb; 42(2):66-75. PubMed ID: 22264668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy.
    Naber KG; Schito G; Botto H; Palou J; Mazzei T
    Eur Urol; 2008 Nov; 54(5):1164-75. PubMed ID: 18511178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pattern of antimicrobial susceptibility in uropathogen isolates from children].
    Suárez VM; Suárez RC; Pérez BA; Alvarez FA; Castro SP; Rodríguez FS; Guerrero SM
    Rev Esp Quimioter; 2001 Mar; 14(1):63-8. PubMed ID: 11376352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative importance of Staphylococcus saprophyticus as a urinary tract pathogen: distribution of bacteria among urinary samples analysed during 1 year at a major Swedish laboratory.
    Eriksson A; Giske CG; Ternhag A
    APMIS; 2013 Jan; 121(1):72-8. PubMed ID: 23030816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Russian results of the international epidemiological study of clinical aspects and resistance to antimicrobial medicines of cystitis uropathogens in females (ARESC): significance of empiric therapy].
    Perepanova TS; Siniakova LA; Zaĭtsev AV; Kozlov RS; Shevelev AN; Gualco L; Achito G; Naber KG
    Urologiia; 2011; (2):30-6. PubMed ID: 21815455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by Japanese Surveillance Committee from 2015 to 2016: antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus.
    Hayami H; Takahashi S; Ishikawa K; Yasuda M; Yamamoto S; Wada K; Kobayashi K; Hamasuna R; Minamitani S; Matsumoto T; Kiyota H; Tateda K; Sato J; Hanaki H; Masumori N; Nishiyama H; Miyazaki J; Fujimoto K; Tanaka K; Uehara S; Matsubara A; Ito K; Hayashi K; Kurimura Y; Ito S; Takeuchi T; Narita H; Izumitani M; Nishimura H; Kawahara M; Hara M; Hosobe T; Takashima K; Chokyu H; Matsumura M; Ihara H; Uno S; Monden K; Sumii T; Kawai S; Kariya S; Sato T; Yoshioka M; Kadena H; Matsushita S; Nishi S; Hosokawa Y; Shirane T; Yoh M; Watanabe S; Makinose S; Uemura T; Goto H
    J Infect Chemother; 2019 Jun; 25(6):413-422. PubMed ID: 30905628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
    Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
    Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of various criteria for elimination of duplicates when calculating the prevalence and antibiotic susceptibility of microorganisms associated with urinary infections.
    Cebrián L; Rodríguez JC; Escribano I; Cascales E; López-Lozano JM; Royo G
    Int J Antimicrob Agents; 2005 Feb; 25(2):173-6. PubMed ID: 15664489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus.
    Hayami H; Takahashi S; Ishikawa K; Yasuda M; Yamamoto S; Uehara S; Hamasuna R; Matsumoto T; Minamitani S; Watanabe A; Iwamoto A; Totsuka K; Kadota J; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Naito S; Tatsugami K; Yamaguchi T; Ito S; Kanokogi M; Narita H; Kawano H; Hosobe T; Takayama K; Sumii T; Fujii A; Sato T; Yamauchi T; Izumitani M; Chokyu H; Ihara H; Akiyama K; Yoshioka M; Uno S; Monden K; Kano M; Kaji S; Kawai S; Ito K; Inatomi H; Nishimura H; Ikuyama T; Nishi S; Takahashi K; Kawano Y; Ishihara S; Tsuneyoshi K; Matsushita S; Yamane T; Hirose T; Fujihiro S; Endo K; Oka Y; Takeyama K; Kimura T; Uemura T
    J Infect Chemother; 2013 Jun; 19(3):393-403. PubMed ID: 23640203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.
    Sadahira T; Wada K; Araki M; Ishii A; Takamoto A; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y; Kumon H;
    J Antimicrob Chemother; 2017 Feb; 72(2):529-534. PubMed ID: 27733519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.
    Schito GC; Naber KG; Botto H; Palou J; Mazzei T; Gualco L; Marchese A
    Int J Antimicrob Agents; 2009 Nov; 34(5):407-13. PubMed ID: 19505803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low frequency of antibiotic resistance among urine isolates of Escherichia coli in the community, despite a major hospital outbreak with Klebsiella pneumoniae producing CTX-M-15 in Uppsala County.
    Lindbäck H; Lindbäck J; Sylvan S; Melhus A
    Scand J Infect Dis; 2010 Apr; 42(4):243-8. PubMed ID: 20085420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
    Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
    Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacterial composition and resistance from urinary tract infections in females].
    Zhao DN; Xiao YH; zhang SL; Wang XX
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):32-7. PubMed ID: 19563060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research of urinary tract infections in family medicine physicians' offices--empiric antimicrobial therapy of urinary tract infections--Croatian experience.
    Skerk V; Skerk V; Jaksić J; Lakos AK; Matrapazovski M; Maleković G; Andrasević AT; Radoaević V; Markotić A; Begovac J
    Coll Antropol; 2009 Jun; 33(2):625-31. PubMed ID: 19662789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of bacterial susceptibility pattern of Escherichia coli in uncomplicated urinary tract infections in a country with high antibiotic consumption: a comparison of two surveys with a 10 year interval.
    De Backer D; Christiaens T; Heytens S; De Sutter A; Stobberingh EE; Verschraegen G
    J Antimicrob Chemother; 2008 Aug; 62(2):364-8. PubMed ID: 18499768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The etiology of urinary tract infection: traditional and emerging pathogens.
    Ronald A
    Dis Mon; 2003 Feb; 49(2):71-82. PubMed ID: 12601338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitroxoline: an option for the treatment of urinary tract infection with multi-resistant uropathogenic bacteria.
    Hof H; Juretschke C
    Infection; 2019 Jun; 47(3):493-495. PubMed ID: 30449013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.